PROCEPT BioRobotics Corporation Statistics
Share Statistics
PROCEPT BioRobotics Corporation has 54.39M shares outstanding. The number of shares has increased by 6.73% in one year.
| Shares Outstanding | 54.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 4.74% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 51.55M |
| Failed to Deliver (FTD) Shares | 17.62K |
| FTD / Avg. Volume | 2.24% |
Short Selling Information
The latest short interest is 6.18M, so 11.36% of the outstanding shares have been sold short.
| Short Interest | 6.18M |
| Short % of Shares Out | 11.36% |
| Short % of Float | 11.99% |
| Short Ratio (days to cover) | 11.44 |
Valuation Ratios
The PE ratio is -18.7 and the forward PE ratio is -71.84.
| PE Ratio | -18.7 |
| Forward PE | -71.84 |
| PS Ratio | 14.54 |
| Forward PS | 10.7 |
| PB Ratio | 7.05 |
| P/FCF Ratio | -14.87 |
| PEG Ratio | n/a |
Enterprise Valuation
PROCEPT BioRobotics Corporation has an Enterprise Value (EV) of 1.80B.
| EV / Earnings | -17.02 |
| EV / Sales | 13.23 |
| EV / EBITDA | -18.37 |
| EV / EBIT | -16.51 |
| EV / FCF | -13.53 |
Financial Position
The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.28.
| Current Ratio | 7.63 |
| Quick Ratio | 6.77 |
| Debt / Equity | 0.28 |
| Total Debt / Capitalization | 22 |
| Cash Flow / Debt | -1.36 |
| Interest Coverage | -27.33 |
Financial Efficiency
Return on equity (ROE) is -0.38% and return on capital (ROIC) is -30.33%.
| Return on Equity (ROE) | -0.38% |
| Return on Assets (ROA) | -0.26% |
| Return on Capital (ROIC) | -30.33% |
| Revenue Per Employee | 217.56K |
| Profits Per Employee | -169.16K |
| Employee Count | 626 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 73.06% in the last 52 weeks. The beta is 1, so PROCEPT BioRobotics Corporation's price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | 73.06% |
| 50-Day Moving Average | 90.26 |
| 200-Day Moving Average | 72.46 |
| Relative Strength Index (RSI) | 41.08 |
| Average Volume (20 Days) | 785.95K |
Income Statement
In the last 12 months, PROCEPT BioRobotics Corporation had revenue of 136.19M and earned -105.90M in profits. Earnings per share was -2.24.
| Revenue | 136.19M |
| Gross Profit | 71.05M |
| Operating Income | -109.17M |
| Net Income | -105.90M |
| EBITDA | -98.09M |
| EBIT | -109.17M |
| Earnings Per Share (EPS) | -2.24 |
Balance Sheet
The company has 257.22M in cash and 79.20M in debt, giving a net cash position of 178.02M.
| Cash & Cash Equivalents | 257.22M |
| Total Debt | 79.20M |
| Net Cash | 178.02M |
| Retained Earnings | -454.57M |
| Total Assets | 374.14M |
| Working Capital | 269.33M |
Cash Flow
In the last 12 months, operating cash flow was -108.00M and capital expenditures -25.21M, giving a free cash flow of -133.21M.
| Operating Cash Flow | -108.00M |
| Capital Expenditures | -25.21M |
| Free Cash Flow | -133.21M |
| FCF Per Share | -2.82 |
Margins
Gross margin is 52.17%, with operating and profit margins of -80.16% and -77.76%.
| Gross Margin | 52.17% |
| Operating Margin | -80.16% |
| Pretax Margin | -77.76% |
| Profit Margin | -77.76% |
| EBITDA Margin | -72.03% |
| EBIT Margin | -80.16% |
| FCF Margin | -97.81% |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.75% |
| FCF Yield | -3% |
Analyst Forecast
The average price target for PRCT is $102, which is 25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $102 |
| Price Target Difference | 25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 20.33 |
| Piotroski F-Score | 3 |